Found: 7
Select item for more details and to access through your institution.
Safety and efficacy of polatuzumab vedotin + obinutuzumab for relapsed/refractory non‐Hodgkin lymphomas: A phase IB/II study.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 1, p. E24, doi. 10.1002/ajh.26400
- By:
- Publication type:
- Article
Long-term Outcomes After Hematopoietic Cell Transplant in Peripheral T-Cell Lymphoma - The Oregon Health and Science University Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 12, p. 874, doi. 10.1016/j.clml.2023.08.010
- By:
- Publication type:
- Article
Autologous haematopoietic cell transplantation for non- Hodgkin lymphoma with secondary CNS involvement.
- Published in:
- British Journal of Haematology, 2013, v. 162, n. 5, p. 648, doi. 10.1111/bjh.12451
- By:
- Publication type:
- Article
A phase II trial of netupitant/palonosetron for prevention of chemotherapy-induced nausea/vomiting in patients receiving BEAM prior to hematopoietic cell transplantation.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 2, p. 304, doi. 10.1177/10781552231173863
- By:
- Publication type:
- Article
Aberrations of MYC Are a Common Event in B-Cell Prolymphocytic Leukemia.
- Published in:
- American Journal of Clinical Pathology, 2014, v. 142, n. 3, p. 347, doi. 10.1309/AJCPUBHM8U7ZFLOB
- By:
- Publication type:
- Article
Costimulatory molecule OX40L is critical for both Th1 and Th2 responses in allergic inflammation.
- Published in:
- European Journal of Immunology, 2002, v. 32, n. 10, p. 2874, doi. 10.1002/1521-4141(2002010)32:10<2874::AID-IMMU2874>3.0.CO;2-4
- By:
- Publication type:
- Article
Targeting the programmed cell death 1 pathway in Hodgkin lymphoma: the place of nivolumab.
- Published in:
- Therapeutic Advances in Hematology, 2017, v. 8, n. 5, p. 175, doi. 10.1177/2040620717695723
- By:
- Publication type:
- Article